Cisplatin/Durvalumab/Gemcitabine/Tremelimumab Regimen

Preferred Label : Cisplatin/Durvalumab/Gemcitabine/Tremelimumab Regimen;

NCIt synonyms : Cisplatin-Durvalumab-Gemcitabine-Tremelimumab; Cisplatin/Imjudo/Gemcitabine/Imfinzi; Cisplatin/Durvalumab/Gemcitabine/Tremelimumab; Tremelimumab/Durvalumab/Gemcitabine/Cisplatin; Cisplatin/Durvalumab/Gemcitabine/Tremelimumab-actl; Imjudo/Imfinzi Plus Cisplatin/Gemcitabine;

NCIt definition : A regimen consisting of cisplatin, durvalumab, gemcitabine and tremelimumab that may be used in the treatment of non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL1922492;

Détails

Origin ID

C203689;

UMLS CUI

C5909401;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Gemcitabine [NCIt concept]
- Tremelimumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients